Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control

Publication date: Available online 28 December 2017
Source:Peptides
Author(s): María L. Fernandez-Cachon, Søren L. Pedersen, Kristoffer T. Rigbolt, Chen Zhang, Katrine Fabricius, Henrik H. Hansen, Lisbeth Elster, Lisbeth N. Fink, Matthias Schäfer, Nicolai A. Rhee, Ebbe Langholz, Erik Wandall, Steffen U. Friis, Peter Vilmann, Viggo B. Kristiansen, Christina Schmidt, Kay Schreiter, Kristin Breitschopf, Thomas Hübschle, Tina Jorsal, Tina Vilsbøll, Thorsten Schmidt, Stefan Theis, Filip K. Knop, Philip Just Larsen, Jacob Jelsing
AimTo determine whether intestinal expression of guanylate cyclase activator 2A (GUCA2A) and guanylate cyclase activator 2B (GUCA2B) genes is regulated in obese humans following Roux-en-Y gastric bypass (RYGB), and to evaluate the corresponding guanylin (GN) and uroguanylin (UGN) peptides for potentially contributing to the beneficial metabolic effects of RYGB.MethodsEnteroendocrine cells were harvested peri- and post-RYGB, and GUCA2A/GUCA2B mRNA expression was compared. GN, UGN and their prohormones (proGN, proUGN) were administered subcutaneously in normal-weight mice to evaluate effects on food intake and glucose regulation. The effect of pro-UGN or UGN overexpression, using adeno-associated virus (AAV) vectors, was assessed in diet-induced obese (DIO) mice. Intracerebroventricular administration of GN and UGN was performed in rats for assessment of putative centrally mediated effects on food intake. GN and UGN, as well as their prohormones, were evaluated for effects on glucose-stimulated insulin secretion (GSIS) in rat pancreatic islets and perfused rat pancreas.ResultsGUCA2A and GUCA2B mRNA expression was significantly upregulated in enteroendocrine cells after RYGB. Peripheral administration of guanylins or prohormones did not influence food intake, oral glucose tolerance, and GSIS. Central administration of GN and UGN did not affect food intake in rats. Chronic AVV-mediated overexpression of UGN and proUGN had no effect on body weight or glucose homeostasis in DIO mice.ConclusionGN and UGN, as well as their prohormones, do not seem to play a significant role in body weight regulation and glycemic control, suggesting that guanylin-family peptides do not show promise as targets for the treatment of obesity or diabetes.



http://ift.tt/2BRGr4V